Clinical trial NCT05977881 - References

HIV Infections — Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study

Citation(s)

•   Allen ST, O'Rourke A, White RH, Smith KC, Weir B, Lucas GM, Sherman SG, Grieb SM
  Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study. AIDS Behav. 2020 Jun;24(6):1942-1950. doi: 10.1007/s10461-019-02767-3.
•   Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, Roosevelt K, Klevens RM, Bryant J, Peters PJ, Lyss SB, Switzer WM, Burrage A, Murray A, Agnew-Brune C, Stiles T, McClung P, Campbell EM, Breen C, Randall LM, Dasgupta S, Onofrey S, Bixler D, Hampton K, Jaeger JL, Hsu KK, Adih W, Callis B, Goldman LR, Danner SP, Jia H, Tumpney M, Board A, Brown C, DeMaria A Jr, Buchacz K
  Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018. Am J Public Health. 2020 Jan;110(1):37-44. doi: 10.2105/AJPH.2019.305366. Epub 2019 Nov 14.
•   Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ
  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014 Feb;43(1):235-48. doi: 10.1093/ije/dyt243. Epub 2013 Dec 27.
•   Atkins A, McClung RP, Kilkenny M, Bernstein K, Willenburg K, Edwards A, Lyss S, Thomasson E, Panneer N, Kirk N, Watson M, Adkins E, DiNenno E, Hogan V, Neblett Fanfair R, Napier K, Ridpath AD, Perdue M, Chen M, Surtees T, Handanagic S, Wood H, Kennebrew D, Cohn C, Sami S, Eubank S, Furukawa NW, Rose B, Thompson A, Spadafora L, Wright C, Balleydier S, Broussard D, Reynolds P, Carnes N, Haynes N, Sapiano T, McBee S, Campbell E, Batdorf S, Scott M, Boltz M, Wills D, Oster AM
  Notes from the Field: Outbreak of Human Immunodeficiency Virus Infection Among Persons Who Inject Drugs - Cabell County, West Virginia, 2018-2019. MMWR Morb Mortal Wkly Rep. 2020 Apr 24;69(16):499-500. doi: 10.15585/mmwr.mm6916a2. No abstract available.
•   Bardwell G, Kerr T
  Drug checking: a potential solution to the opioid overdose epidemic? Subst Abuse Treat Prev Policy. 2018 May 25;13(1):20. doi: 10.1186/s13011-018-0156-3.
•   Bazzi AR, Biancarelli DL, Childs E, Drainoni ML, Edeza A, Salhaney P, Mimiaga MJ, Biello KB
  Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs. AIDS Patient Care STDS. 2018 Dec;32(12):529-537. doi: 10.1089/apc.2018.0126. Epub 2018 Oct 11.
•   Beletsky L, Davis CS
  Today's fentanyl crisis: Prohibition's Iron Law, revisited. Int J Drug Policy. 2017 Aug;46:156-159. doi: 10.1016/j.drugpo.2017.05.050. Epub 2017 Jul 18.
•   Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA
  Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet. 2010 Aug 14;376(9740):551-63. doi: 10.1016/S0140-6736(10)60928-2.
•   Biello KB, Bazzi AR, Vahey S, Harris M, Shaw L, Brody J
  Delivering Preexposure Prophylaxis to People Who Use Drugs and Experience Homelessness, Boston, MA, 2018-2020. Am J Public Health. 2021 Jun;111(6):1045-1048. doi: 10.2105/AJPH.2021.306208.
•   Brunt TM, Nagy C, Bucheli A, Martins D, Ugarte M, Beduwe C, Ventura Vilamala M
  Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project. Drug Test Anal. 2017 Feb;9(2):188-198. doi: 10.1002/dta.1954. Epub 2016 Feb 17.
•   Centers for Disease Control and Prevention
  HIV Infection Risk, Prevention, and Testing Behaviors among Persons Who Inject Drugs-National HIV Behavioral Surveillance: Injection Drug Use, 23 U.S. Cities, 2018. 2020;24:43.
•   Centers for Disease Control and Prevention
  HIV Infection Risk, Prevention, and Testing Behaviors among Persons Who Inject Drugs-National HIV Behavioral Surveillance: Injection Drug Use, 23 U.S. Cities, 2018. HIV Surveillance Special Report. 2020;24.
•   Centers for Disease Control and Prevention
  Preexposure prophylaxis for the prevention of HIV infection in the United States-2014: a clinical practice guideline. Atlanta: Centers for Disease Control and Prevention. 2014:67.
•   Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D
  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1337-41. doi: 10.15585/mmwr.mm6448a3.
•   Drug Enforcement Agency
  National Heroin Threat Assessment Summary - Updated. United States Drug Enforcement Administration;2016. DEA-DCT-DIR-031-16.
•   Escudero DJ, Kerr T, Wood E, Nguyen P, Lurie MN, Sued O, Marshall BD
  Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting. AIDS Behav. 2015 May;19(5):752-7. doi: 10.1007/s10461-014-0867-z.
•   Gale NK, Heath G, Cameron E, Rashid S, Redwood S
  Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013 Sep 18;13:117. doi: 10.1186/1471-2288-13-117.
•   Geddes L, Iversen J, Memedovic S, Maher L
  Intravenous fentanyl use among people who inject drugs in Australia. Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S314-S322. doi: 10.1111/dar.12668. Epub 2018 Feb 6.
•   Glick SN, Prohaska SM, LaKosky PA, Juarez AM, Corcorran MA, Des Jarlais DC
  The Impact of COVID-19 on Syringe Services Programs in the United States. AIDS Behav. 2020 Sep;24(9):2466-2468. doi: 10.1007/s10461-020-02886-2. No abstract available.
•   Harper L, Powell J, Pijl EM
  An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services. Harm Reduct J. 2017 Jul 31;14(1):52. doi: 10.1186/s12954-017-0179-5.
•   Hedegaard H, Minino AM, Warner M
  Drug Overdose Deaths in the United States, 1999-2017. NCHS Data Brief. 2018 Nov;(329):1-8.
•   Hershow RB, Gonzalez M, Costenbader E, Zule W, Golin C, Brinkley-Rubinstein L
  Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs. AIDS Educ Prev. 2019 Aug;31(4):363-379. doi: 10.1521/aeap.2019.31.4.363.
•   Jo Y, Bartholomew TS, Doblecki-Lewis S, Rodriguez A, Forrest DW, Tomita-Barber J, Oves J, Tookes HE
  Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida. PLoS One. 2020 Apr 16;15(4):e0231424. doi: 10.1371/journal.pone.0231424. eCollection 2020.
•   Kuo I, Olsen H, Patrick R, Phillips G 2nd, Magnus M, Opoku J, Rawls A, Peterson J, Hamilton F, Kharfen M, Greenberg A
  Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug Alcohol Depend. 2016 Jul 1;164:8-13. doi: 10.1016/j.drugalcdep.2016.02.044. Epub 2016 Mar 15.
•   Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH
  Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019 Dec;74:299-304. doi: 10.1016/j.drugpo.2019.10.004. Epub 2019 Nov 13.
•   Maryland Department of Health
  Unintentional drug- and alcohol-related intoxication deaths in Maryland annual report 2017. Annapolis, Maryland. 2017.
•   Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL
  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019. MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207. doi: 10.15585/mmwr.mm7006a4.
•   Mayer KH, Agwu A, Malebranche D
  Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Adv Ther. 2020 May;37(5):1778-1811. doi: 10.1007/s12325-020-01295-0. Epub 2020 Mar 30.
•   McFarland W, Lin J, Santos GM, Arayasirikul S, Raymond HF, Wilson E
  Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018. AIDS Behav. 2020 May;24(5):1290-1293. doi: 10.1007/s10461-019-02682-7.
•   Mistler CB, Copenhaver MM, Shrestha R
  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review. AIDS Behav. 2021 May;25(5):1490-1506. doi: 10.1007/s10461-020-02988-x.
•   Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG
  Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Drug Alcohol Depend. 2019 Nov 1;204:107547. doi: 10.1016/j.drugalcdep.2019.107547. Epub 2019 Aug 23.
•   Murphy SL, Xu J, Kochanek KD, Arias E
  Mortality in the United States, 2017. NCHS Data Brief. 2018 Nov;(328):1-8.
•   O'Donnell J, Gladden RM, Mattson CL, Kariisa M
  Notes from the Field: Overdose Deaths with Carfentanil and Other Fentanyl Analogs Detected - 10 States, July 2016-June 2017. MMWR Morb Mortal Wkly Rep. 2018 Jul 13;67(27):767-768. doi: 10.15585/mmwr.mm6727a4. No abstract available.
•   Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE
  Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019 Jan;63:122-128. doi: 10.1016/j.drugpo.2018.08.007. Epub 2018 Oct 3.
•   Roth A, Tran N, Piecara B, Welles S, Shinefeld J, Brady K
  Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015. AIDS Behav. 2019 Jul;23(7):1833-1840. doi: 10.1007/s10461-018-2293-0.
•   Roth AM, Aumaier BL, Felsher MA, Welles SL, Martinez-Donate AP, Chavis M, Van Der Pol B
  An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users. Sex Transm Dis. 2018 Apr;45(4):217-221. doi: 10.1097/OLQ.0000000000000728.
•   Rouhani S, Park JN, Morales KB, Green TC, Sherman SG
  Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Harm Reduct J. 2019 Jun 24;16(1):39. doi: 10.1186/s12954-019-0311-9.
•   Rudd RA, Aleshire N, Zibbell JE, Gladden RM
  Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.
•   Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC
  Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019 Jun;68:46-53. doi: 10.1016/j.drugpo.2019.03.003. Epub 2019 Apr 13.
•   Sherman SG, Park JN, Glick J, et al
  FORECAST Study Summary Report. Johns Hopkins Bloomberg School of Public Health. 2018.
•   Sherman SG, Schneider KE, Park JN, Allen ST, Hunt D, Chaulk CP, Weir BW
  PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug Alcohol Depend. 2019 Feb 1;195:148-155. doi: 10.1016/j.drugalcdep.2018.08.014. Epub 2018 Oct 22.
•   Shrestha R, Copenhaver M
  Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment. Front Public Health. 2018 Jul 13;6:195. doi: 10.3389/fpubh.2018.00195. eCollection 2018.
•   Stein M, Thurmond P, Bailey G
  Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS Behav. 2014 Sep;18(9):1694-700. doi: 10.1007/s10461-014-0778-z.
•   Strathdee SA, Beyrer C
  HIV Outbreak in Indiana. N Engl J Med. 2015 Oct;373(14):1380-1. doi: 10.1056/NEJMc1510396. No abstract available.
•   Walters SM, Reilly KH, Neaigus A, Braunstein S
  Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017 Jun 29;14(1):40. doi: 10.1186/s12954-017-0166-x.
•   Walters SM, Rivera AV, Starbuck L, Reilly KH, Boldon N, Anderson BJ, Braunstein S
  Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013. J Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3:S383-S391. doi: 10.1097/QAI.0000000000001415.
•   Wilson N, Kariisa M, Seth P, Smith H 4th, Davis NL
  Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.

Impact of a Novel HIV Peer Navigation and Overdose Prevention Intervention on Engagement in the HIV Prevention and Treatment Cascade

Details for clinical trial NCT05977881